Nicaragua vs Tajikistan: Treatment success rate for patients treated for MDR-TB
Nicaragua
86.0%
in 2021
Tajikistan
86.0%
in 2022
Nicaragua rank
31st
Tajikistan rank
31st
Treatment success rate for patients treated for MDR-TB over time
- Nicaragua
- Tajikistan
How they compare
Nicaragua currently reports 86.0% against 86.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 3 times across 11 shared years of data; in 2009 it was Tajikistan ahead.
Nicaragua ranks 31st and Tajikistan ranks 31st of 163 countries.
Across the 3 decades both report, Nicaragua averaged higher in 1 and Tajikistan in 2.
Head to head by decade
| Decade | Nicaragua | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 38.0% | 71.0% | 33.0% | Tajikistan |
| 2010s | 69.6% | 63.6% | 6.0% | Nicaragua |
| 2020s | 78.5% | 83.0% | 4.5% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Nicaragua or Tajikistan?
- Nicaragua, at 86.0% against 86.0% in Tajikistan as of 2021.
- What is the difference in treatment success rate for patients treated for mdr-tb between Nicaragua and Tajikistan?
- 0.0%, with Nicaragua ahead.
- How many years of comparable data are there for Nicaragua and Tajikistan?
- 11 years are reported by both, from 2009 to 2021.
- How do Nicaragua and Tajikistan rank globally for treatment success rate for patients treated for mdr-tb?
- Nicaragua ranks 31st and Tajikistan ranks 31st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.